je.st
news
Eli Lilly and Price Target Raised to $93.00 at Leerink Swann
2015-09-08 00:18:56| Biotech - Topix.net
The brokerage currently has an "outperform" rating on the stock. Leerink Swann's price objective points to a potential upside of 15.79% from the company's previous close.
Tags: price
target
raised
eli
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||